Wannan shafin yana aiwatar da ayyuka na asali kuma bai shirya don amfanin marasa lafiya ba tukuna.
Wannan shafin yana aiwatar da ayyuka na asali kuma bai shirya don amfanin marasa lafiya ba tukuna.
Cutar ƙwayar cuta mai kisa wadda ake kamuwa ta hanyar cizon dabbobi, musamman karnuka, jemagu, da namun daji. Allurar rigakafi tana ba da kariya kafin hulɗa da cutar.
Cutar ƙwayar cuta mai kisa wadda ake kamuwa ta hanyar cizon dabbobi, musamman karnuka, jemagu, da namun daji. Allurar rigakafi tana ba da kariya kafin hulɗa da cutar.
Matafiya zuwa yankunan da ake samun cutar, likitocin dabbobi, masu kulawa da dabbobi, masu binciken kogwanni, ma'aikatan dakin gwaje-gwaje.
Pregnancy: Safe — must be given for post-exposure prophylaxis (PEP).
Rabies vaccine is an inactivated cell-culture vaccine and is safe during pregnancy.
Post-exposure prophylaxis (PEP): NO contraindications exist — rabies PEP must be administered regardless of pregnancy, gestational age, or any other condition. Rabies is nearly 100% fatal once symptomatic.
Pre-exposure prophylaxis: safe to administer during pregnancy when occupational or travel risk warrants it.
WHO: pregnancy is not a contraindication for either PrEP or PEP.
No teratogenic effects observed in published case series.
Breastfeeding: Safe — no restrictions.
Rabies vaccine is inactivated and completely safe during breastfeeding. PEP must never be withheld or delayed for any reason, including breastfeeding. No modification to breastfeeding required.
Pediatric use:
No minimum age restriction — rabies vaccine can be given to infants if needed for PEP.
Children are at higher risk of animal bites (especially from dogs) and may not report exposures.
WHO intradermal regimen (0.1 mL ID) approved for children — reduces cost significantly.
Pre-exposure: recommended for children with prolonged travel to rabies-endemic areas (especially if staying in rural settings).
Same dose as adults: 0.5 mL or 1.0 mL IM depending on formulation.
Geriatric use:
No specific age-related contraindications. Standard dose and schedule apply.
Immunocompromised elderly patients may have a reduced antibody response — check antibody titer (≥0.5 IU/mL) after pre-exposure vaccination or PEP completion.
PEP must never be withheld based on age.
| Allura | Alama | Kwanaki daga na baya | Kewayon shekaru |
|---|---|---|---|
| Allura 1 | Imovax Rabies | — | — |
| Allura 1 | Imovax Rabies | — | — |
| Allura 2 | Imovax Rabies | 7d | — |
| Allura 2 | Imovax Rabies | 3d | — |
| Allura 3 | Imovax Rabies | 4d | — |
| Allura 4 | Imovax Rabies | 7d | — |
Kun san allurar rigakafin da kuke bukata? Da kyau. Ba ku sani ba? Ku gaya mana inda kuke tafiya — za mu nemo allurar da ta dace da asibiti. Kyauta, ba tare da wani hakki ba.
Abun ciki a wannan shafin don bayani da ilimi ne kawai. Ba ya zama shawarar likita, gano cuta, ko shawarwarin magani ba. Idan kuna da damuwar lafiya, tuntuɓi ƙwararren ma’aikacin lafiya. Medova ba mai ba da sabis na likitanci ba ne.
Cikakkun sharuɗɗan amfaniJerin dubawa da hanya: inda za ka je, lokaci, haɗari da lokacin ganin likita.